COSMOS Pharmaceutical (ticker 3349) reported its Q3 2026 financial results on October 13, 2026, before market open. The company posted earnings per share of 104.11 JPY, beating the analyst estimate of 102.83 JPY by 1.2%. Reported revenue reached 286653 million JPY. Following the release, the stock price moved by -2.16%.
Generated automatically from our data — as of October 14, 2026
Key figures at a glance
Estimate (EPS): 102.83 JPY
Reported (EPS): 104.11 JPY
Price reaction: -2.2%
Frequently asked questions
Did COSMOS Pharmaceutical beat or miss earnings-per-share expectations?
COSMOS Pharmaceutical beat the analyst estimate of 102.83 JPY earnings per share (Q3 2026) by 1.2%, reporting 104.11 JPY.
How did COSMOS Pharmaceutical stock react to the earnings report?
COSMOS Pharmaceutical stock fell 2.2% on the trading day following the release.
What was COSMOS Pharmaceutical's revenue in Q3 2026?
COSMOS Pharmaceutical reported revenue of 286,653M JPY in Q3 2026.